Funding the Firm: Where the Capital Comes From

A patent brokerage firm is an unusual thing to fund. You are not buying premises, inventory, or machinery. You are buying time, expertise, and a buyer network, then waiting months for a transaction to close. That makes the funding conversation different from almost any other small business, and it is the part most founders get wrong when they walk into a lender's office.

The dominant US route is the SBA 7(a) loan, which funds working capital for service firms up to $5 million. For an asset-light advisory business like a brokerage, the SBA Microloan program (up to $50,000, average around $16,000) is often the more realistic first draw, since lenders are wary of writing large facilities against commission income that arrives in irregular lumps. SBA 7(a) lenders approved roughly half of submitted applications in recent years, and the strongest files for professional-services firms lead with the founder's track record and a concrete pipeline rather than smooth revenue projections.

In the UK, the government-backed Start Up Loan offers up to £25,000 per founder at 6% fixed, with free mentoring attached. Two co-founders can stack to £50,000, which is often enough to cover the first year of analytics subscriptions and a modest marketing push while the firm builds its buyer relationships. Most brokerage founders blend a small facility with personal savings, because the honest pitch to any lender is that revenue is back-loaded: the firm spends for months on analysis and outreach before a single commission lands.

The investor angle matters too. Patent brokerages rarely raise equity, but the few that scale into a platform model, combining brokerage, analytics, and a recurring buyer-network subscription, have attracted private capital. If that is your ambition, the plan needs to separate the lumpy transactional core from any recurring-revenue layer so an investor can see where a multiple-bearing business actually lives. We cover that split in the revenue model section below.

Brokered Patent Market: Size & Demand

The brokered patent market is small, specialised, and surprisingly well-documented. In 2024 the total value of brokered patent transactions came to roughly $158 million, broadly in line with 2022 and 2023, according to the annual market report produced by Richardson Oliver Insights and published through IAM, 2025. That is the addressable transaction pool that brokerage commissions are skimmed from, and understanding its shape is the single most important input to a credible plan.

Three structural facts shape every brokerage plan. First, only about 21% of patent packages brought to the brokered market actually sell; Richardson Oliver Insights has tracked over $38 billion of assets offered for sale since it began monitoring, and the vast majority never close. Second, average asking prices sit in the $200,000 to $300,000 range per US-issued patent, and asking prices typically run ahead of closing prices, per Tangible IP, 2024. Third, packages backed by a credible Evidence of Use (EoU) analysis command a roughly 28% price premium over those without, which is exactly why the analysis budget is a core line item in your launch costs, not an optional extra.

The wider context is more buoyant than the brokered slice alone suggests. Allied Market Research valued the global IP trading market at around $7.4 billion in 2020, projecting roughly $34 billion by 2030, and the adjacent patent-licensing market is forecast to reach $4.4 billion by 2032 at a 7.77% compound rate. A brokerage that can plug into licensing and litigation-finance demand, not just outright sales, sits in a much larger pool than the $158 million brokered headline implies. The plan should make that adjacency explicit so a reader does not mistake the narrow brokered figure for the firm's true ceiling.

Demand is concentrated. The most active buyers are operating companies in wireless, semiconductors, cloud computing, OLED displays, and automotive, alongside a smaller set of patent assertion entities and litigation funders. A 2024 collaboration between IAM, Richardson Oliver Insights, and brokers including Dynamic IP Deals, ICEBERG IP Group, Tangible IP, and Transactions IP put tens of millions of dollars of assets on the market in energy storage, smartphones, and semiconductors, a useful signal of where buyer appetite actually concentrates.

Your Two-Sided Market: Sellers and Buyers

A patent brokerage is a two-sided business, and the plan has to address both sides explicitly. You earn from sellers, the inventors, universities, distressed startups, and corporate IP departments who hand you a mandate, but you only earn when a buyer pays. Confusing the two, or assuming that winning sellers is the hard part, is the most common strategic error in a first draft.

The Sell Side: Who Brings You Mandates

Mandate flow comes from a handful of recognisable sources, each with a different motivation and a different ideal pitch.

• Distressed and wind-down startups: companies shutting down or pivoting, whose patents are a non-core asset to be liquidated quickly. Time pressure is high; price expectations are usually realistic. This is some of the highest-quality mandate flow because sellers are motivated.
• Corporate IP departments: large firms pruning portfolios to cut maintenance fees on patents they no longer practice. Volume is high, but these sellers are sophisticated and will hold out for full value.
• Universities and research institutions: tech-transfer offices sitting on granted patents with no commercialisation path. Long sales cycles, but a steady, renewable source if you build the relationship.
• Independent inventors: the hardest segment. Emotional attachment and inflated price expectations mean most of these mandates fall into the ~79% that never close. Screen ruthlessly.

The Buy Side: Who Actually Pays

Buyers are fewer, more sophisticated, and far harder to reach cold. Your buyer network is the single most defensible asset the firm owns, and the plan should treat building it as a capital investment, not a marketing line.

• Operating companies: acquiring patents defensively (to deter litigation) or offensively (to strengthen their cross-licensing position). Concentrated in wireless, semiconductors, cloud, displays, and automotive.
• Patent assertion entities: buyers who acquire to license or litigate. A smaller, more opportunistic pool whose appetite swings with the litigation climate.
• Litigation funders and IP investment vehicles: increasingly active, buying assets with strong Evidence of Use to back assertion campaigns. This is where the EoU premium gets paid.

The plan should quantify, even roughly, how many active buyer relationships the firm has or will build in year one, because that number, not the size of the seller pipeline, caps how much revenue the firm can actually realise. A brokerage with a hundred mandates and three buyer relationships is a brokerage that will not close.

It is also worth being explicit about geography. The deepest buyer pool sits in the United States, where the litigation system makes patents commercially meaningful and where most of the $158 million brokered market is transacted. A UK or European founder can absolutely run a brokerage, but the plan should acknowledge that a meaningful share of buyers, and often the closing itself, will be cross-border. That has practical consequences for currency, for which patent office records the assignment, and for how the firm bills, all details a careful reader will look for and most first drafts omit.

What It Costs to Open a Brokerage

The good news for cash-strapped founders: a patent brokerage is one of the cheapest professional-services firms to start, because it has almost no physical footprint. The bad news: most of the spend goes into intangibles a lender cannot repossess, which is precisely why the funding case has to be built on the founder's pipeline and credibility. A realistic launch budget runs $15,000 to $120,000 (£12,000 to £95,000), with the spread driven mostly by how much claim-charting and analytics horsepower you buy in the first year.

Cost Breakdown

• Patent analytics subscriptions: $6K-$30K/yr (£5K-£24K). Tools such as PatSnap, Clarivate Derwent, and Questel feed your prior-art search, landscape mapping, and buyer-targeting. This is the recurring spine of the firm.
• Evidence-of-Use / claim-charting budget: $5K-$25K (£4K-£20K). The single highest-impact spend, because EoU-backed packages fetch a ~28% premium and are far likelier to sit inside that 21% of mandates that actually close.
• Marketing & buyer-network development: $3K-$25K (£2.5K-£20K). Conference attendance, a credible website, and direct outreach to corporate IP buyers. Your network is the asset.
• Professional indemnity & errors-and-omissions insurance: $2K-$8K (£1.5K-£6K). Essential when you are advising on six- and seven-figure transactions.
• CRM & deal-pipeline tooling: $1K-$6K (£0.8K-£5K). A brokerage lives or dies on follow-up discipline across a long, multi-touch sales cycle.
• Entity formation, legal templates & accounting: $1K-$5K (£0.8K-£4K). Mandate agreements, NDAs, and assignment paperwork that hold up at closing.

Funding Routes

In the US, the SBA 7(a) program covers working capital up to $5M, while the SBA Microloan program is the more common entry facility for an asset-light advisory firm. In the UK, the Start Up Loan provides up to £25,000 per founder at 6% fixed. Because the firm has little to pledge as collateral, most founders combine a modest facility with personal runway and a clearly evidenced deal pipeline. A related route some founders explore is a research-backed plan used purely to win a bank line of credit against forecast commissions.

Commission Revenue & Unit Economics

Patent brokers get paid the way real-estate agents do: mostly on success, mostly as a percentage, and mostly in lumps. The standard sell-side arrangement is a contingency commission of 15% to 35% of the net sale price, rising to 20% to 40% for full-service portfolio mandates where the broker funds the analysis, per UpCounsel, 2024. Some brokers add an upfront engagement fee of $5,000 to $15,000 to cover analysis and outreach; the most confident work on pure contingency and absorb the infringement-analysis cost themselves.

A Worked Example

Take a single boutique mandate. A seller engages your firm to sell a small portfolio. After your EoU analysis and buyer outreach, it closes at a $250,000 net sale price on a 25% contingency. Your commission on that one transaction is $62,500. Close four comparable deals across a year and the firm books roughly $250,000 in gross commission against a largely fixed overhead, the analytics subscriptions, insurance, and your own time. That is the entire economic engine of a boutique brokerage, and it is why deal selection, not deal volume, is the metric that matters.

Now layer in the close rate. If only one in five marketed packages sells, then to bank those four closings you may need to take on and work fifteen to twenty mandates. The plan has to model that funnel honestly: time spent on the ~79% that never close is real cost with no offsetting revenue. The brokers who outperform are the ones who say no early, declining mandates with weak claims, no evidence of use, or unrealistic seller price expectations, rather than chasing every portfolio that walks in.

Two secondary revenue streams can smooth the lumpiness. Patent valuation and landscape reports sold as standalone advisory work generate predictable fee income between transactions. And a recurring buyer-network or alert subscription, selling curated deal flow to corporate IP teams, converts part of the business into the kind of recurring revenue that supports a real valuation multiple. The plan should keep these distinct from the transactional core so a lender or investor can see the firm's cash-flow shape clearly rather than averaging it into a misleadingly smooth line.

Three Brokerage Models Compared

"Patent brokerage" covers at least three distinct business models, and your plan should commit clearly to one. They differ in cash-flow shape, capital needs, and the kind of founder they suit. Most guides on this topic blur them together; the number that actually separates them is how much risk the broker carries before a deal closes.

The named firms in this market map onto these models. Tangible IP, which reports having brokered over 3,000 patents, and IPOfferings, recognised as a leading full-service broker, sit at the high-touch contingency end. ICAP Patent Brokerage has run a transaction-process model for two decades. Tynax blends brokerage with strategy advisory, while Richardson Oliver Insights (ROL Group) built a data and reports business adjacent to brokering, the clearest example of the platform pivot. Knowing where you sit relative to these incumbents is half of your positioning section.

Operations & Go-to-Market

Operations is where a brokerage's close rate is actually made or lost, and it is the section lenders read most carefully because it shows whether the founder understands the work or just the headline economics. The core workflow runs from mandate intake through analysis, marketing, negotiation, and closing, and each stage has a decision point where a weak deal should be killed before it consumes more time.

The Deal Workflow

• Intake and screening: assess claim strength, remaining patent life, market relevance, and seller price expectations. This is where you decline the mandates that would drag your close rate below the 21% baseline.
• Valuation and Evidence-of-Use: build the claim charts that map the patent onto products in the market. This is the spend that earns the 28% premium and turns a speculative listing into a sellable package.
• Marketing and outreach: confidential approaches to your buyer network, not a public auction. Discretion protects the seller and the asset's value.
• Negotiation and closing: manage price, terms, and the assignment paperwork, then record the transfer with the relevant patent office. Commission is invoiced on the net closing price.

Go-to-Market Priorities for Year One

Marketing a brokerage is relationship-led, not traffic-led. The acquisition model that works is narrow and high-touch.

• Buyer-network development: the highest-priority activity. Direct relationships with corporate IP directors and funders are what convert mandates into commissions.
• Industry presence: speaking, writing, and attending IP conferences (such as IPBC and IAM events) where both sellers and buyers gather.
• Referral channels: patent attorneys, IP litigators, and insolvency practitioners who encounter sellable portfolios and refer them out.
• Content and search: a credible site that captures sellers searching for how to sell a patent, a slower channel, but one that compounds.

Tie each channel to a realistic mandate-flow assumption and a cost. A brokerage that wins mandates it cannot place has a sell-side problem disguised as a buy-side success. The forecast should reconcile mandates in, deals out, and the working-capital gap in between, the single reconciliation a working-capital lender will check first.

More Questions Founders Ask

How do patent brokers get paid?

Almost always on success. The dominant structure is a contingency commission paid only when a sale closes, typically 15-35% of the net price, with some brokers adding a modest upfront engagement fee or working on a hybrid retainer. Because payment is back-loaded and irregular, a broker can go months without income and then book a large cheque, which is exactly why working-capital planning dominates the funding conversation.

What is the difference between a patent broker and a patent attorney?

A patent attorney prosecutes applications and gives regulated legal advice; in the UK that title is protected by IPReg. A patent broker is a commercial intermediary who markets and sells existing granted patents and is not, in itself, a regulated role. Many strong brokers hold patent qualifications, but the broker's edge is a buyer network and deal-making skill, not the ability to file applications.

Can you run a patent brokerage as a solo founder?

Yes, and most are small. Patent brokers typically operate like compact consulting firms, and it is unusual for one to exceed about ten staff. A solo founder with a strong network and outsourced claim-charting can run a viable boutique, which is part of why the launch cost stays low. The constraint is rarely headcount; it is the size and quality of the buyer relationships one person can sustain.

Is patent brokerage a good business to start in 2026?

It rewards a specific profile: deep IP knowledge, patience for long sales cycles, and the relationships to reach buyers. The brokered market is steady rather than explosive (around $158M a year), but the adjacent licensing and litigation-finance pools are growing, and the platform model offers a path to scale. It is a poor fit for anyone needing predictable monthly income from day one.

Credentials, Regulation & Legal Footing

Here is the fact that surprises most founders: patent brokerage is essentially unregulated in the major markets. There is no patent-broker license to obtain in the US or UK. Anyone can broker a patent sale. That lowers the barrier to entry, but it also means trust, credentials, and clean contracts are the things that win mandates, there is no regulator standing behind you.

United States

• No dedicated patent-broker license, the activity is unregulated at federal and state level.
• USPTO registration (patent agent or attorney) is required only to prosecute applications before the office, not to broker. It is a credibility signal, not a legal prerequisite for brokerage. Registration costs a $118 application fee plus a $226 examination fee through the USPTO Office of Enrollment and Discipline, and demands a science or engineering degree plus the patent bar.
• Business entity formation (LLC or corporation) and an EIN from the IRS.
• State business license and any local registration; assignment of sold patents must be recorded with the USPTO.
• Watered, written mandate agreements and NDAs, your real legal protection in an unregulated field.

United Kingdom

• Companies House registration (24 hours online, £12-£50).
• The titles "patent attorney" and "patent agent" are protected and regulated by IPReg, the Intellectual Property Regulation Board. A broker who is not a registered attorney must not use them.
• IP assignment and sale transactions are typically handled alongside IP solicitors; structure referral relationships rather than implying you provide regulated legal advice.
• VAT registration once turnover exceeds £90,000; professional indemnity insurance.
• HMRC registration and standard employer obligations if you hire.

Other Jurisdictions

• European Union: brokerage itself is largely unregulated, but representation before the EPO requires a European Patent Attorney qualification. Cross-border assignments must be recorded with each relevant national or regional office.
• Canada: a federal Business Number from the CRA is needed to operate; brokering is unregulated, though practice before CIPO requires a registered patent agent.

The practical takeaway for your plan: lean on credentials and contracts, not licenses. A USPTO-registered founder, airtight mandate paperwork, and professional indemnity cover do more to win a seven-figure mandate than any badge a regulator could issue. For a deeper look at the formation steps, see our free business plan templates hub.

Mistakes That Sink New Brokerages

The failure modes in this business are specific and avoidable. A lender or investor reading your plan will be reassured if you name them and show how the firm sidesteps each one.

• Modeling smooth monthly revenue. Broker income is lumpy, a handful of closings a year, with long gaps. A forecast that draws a tidy upward line tells a sophisticated reader you do not understand the business. Show the runway between closings instead.
• Taking on unsellable mandates. With only ~21% of marketed packages closing, accepting weak portfolios burns your time and your buyer goodwill. Document the deal-selection criteria that keep your close rate above the market baseline.
• Skipping the Evidence-of-Use work. EoU-backed packages fetch a ~28% premium and are far likelier to sell. Treating claim-charting as an optional cost rather than a core investment is a false economy that shows up directly in revenue.
• Misusing protected titles. Branding the firm as offering "patent attorney" services without IPReg standing (UK) or implying regulated legal advice you are not authorised to give invites complaints and undermines credibility.
• Underpricing the contingency. Cutting below the 15-35% range to win a mandate starves the firm of the working capital it needs to fund analysis on the next deal. Price for the dry spells, not the wins.

Sample Plan Preview

Preview the structure and financial outputs a buyer receives. These visual mockups are generated from the same assumptions used throughout this page.

What's in the Template

Every Avvale business plan template includes these sections, pre-structured for the patent brokerage business:

• Executive Summary, the firm at a glance, framed for a working-capital lender or strategic partner
• Company Overview, legal structure, founder credentials, and chosen brokerage model
• Market Analysis, brokered-market size, close rates, and buyer concentration with citations
• Customer Analysis, sellers (the mandate side) and buyers (operating companies, funders) profiled separately
• Competitor Analysis, positioning against named incumbents and your differentiation
• Marketing Plan, buyer-network development, conference strategy, and outreach cadence
• Operations Plan, mandate intake, deal-selection criteria, EoU workflow, and closing process
• Management Team, founder IP background, advisory board, and key hires

The optional Financial Forecast add-on (included in our $300/£250 and $1,000/£800 packages) provides a 5-year Excel model with a commission-based income statement, lumpy-revenue cash flow, balance sheet, break-even analysis, and the working-capital runway lenders scrutinise.

Frequently Asked Questions

Related Business Plan Guides

Founders launching a patent brokerage often compare it against adjacent IP and financial-advisory models. These guides cover neighbouring niches:

• Forex Brokerage Firm Business Plan Template, another contingency-and-spread brokerage model with heavier regulation.
• Commodity Brokerage Business Plan Template, intermediary economics in a different asset class.
• Bespoke Business Plan, full done-for-you build with a 5-year commission-based forecast.

Useful Links & Resources

These links were preserved from the live page so important references and partner links are not lost during the page refresh.

• Facebook
• Instagram
• LinkedIn
• YouTube